DRUG · Unmapped registry intervention
HL231 Solution for Inhalation
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD
NCT06643078
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Ultibro 110μg/50 μg
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Haisco Pharmaceutical Group Co., Ltd.lead sponsor
Sichuan Haisco Pharmaceutical Group Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06643078 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.